These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


428 related items for PubMed ID: 11495700

  • 1. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH, Mulcahy JM, McKearn JP, Streeter PR.
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [Abstract] [Full Text] [Related]

  • 2. Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor.
    Streeter PR, Minster NI, Kahn LE, Hood WF, Vickery LE, Thurman TL, Monahan JB, Welply JK, McKearn JP, Woulfe SL.
    Exp Hematol; 2001 Jan; 29(1):41-50. PubMed ID: 11164104
    [Abstract] [Full Text] [Related]

  • 3. Activation of the G-CSF and Flt-3 receptors protects hematopoietic stem cells from lethal irradiation.
    Streeter PR, Dudley LZ, Fleming WH.
    Exp Hematol; 2003 Nov; 31(11):1119-25. PubMed ID: 14585378
    [Abstract] [Full Text] [Related]

  • 4. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ, Farese AM, Davis TA, Lind LB, McKearn JP.
    Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
    [Abstract] [Full Text] [Related]

  • 5. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD.
    Blood; 1997 Nov 01; 90(9):3781-8. PubMed ID: 9345066
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.
    Yan XQ, Hartley C, McElroy P, Chang A, McCrea C, McNiece I.
    Blood; 1995 May 01; 85(9):2303-7. PubMed ID: 7537109
    [Abstract] [Full Text] [Related]

  • 7. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.
    Blood; 2003 Mar 01; 101(5):2033-42. PubMed ID: 12393418
    [Abstract] [Full Text] [Related]

  • 8. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.
    Neben S, Marcus K, Mauch P.
    Blood; 1993 Apr 01; 81(7):1960-7. PubMed ID: 7681707
    [Abstract] [Full Text] [Related]

  • 9. Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist.
    Kahn LE, Doshi PD, McGarity KL, Yu M, Bono CP, Lie WR, Rankin AM, Smidt ML, Streeter PR, Klein BK, Welply JK, Woulfe SL.
    Med Sci Monit; 2002 Dec 01; 8(12):BR504-14. PubMed ID: 12503028
    [Abstract] [Full Text] [Related]

  • 10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr 01; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 11. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
    Di Giacomo F, Lewandowski D, Cabannes E, Nancy-Portebois V, Petitou M, Fichelson S, Romeo PH.
    Haematologica; 2012 Apr 01; 97(4):491-9. PubMed ID: 22180429
    [Abstract] [Full Text] [Related]

  • 12. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
    Kaur S, Sehgal A, Wu AC, Millard SM, Batoon L, Sandrock CJ, Ferrari-Cestari M, Levesque JP, Hume DA, Raggatt LJ, Pettit AR.
    J Hematol Oncol; 2021 Jan 06; 14(1):3. PubMed ID: 33402221
    [Abstract] [Full Text] [Related]

  • 13. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C, Di Nicola M, Magni M, Longoni P, Milanesi M, Stucchi C, Cleris L, Formelli F, Gianni MA.
    Cancer Res; 2002 Nov 01; 62(21):6152-7. PubMed ID: 12414641
    [Abstract] [Full Text] [Related]

  • 14. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun 01; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 15. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK.
    Biol Blood Marrow Transplant; 2013 Mar 01; 19(3):460-7. PubMed ID: 23201472
    [Abstract] [Full Text] [Related]

  • 16. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE.
    J Immunol; 1996 Oct 01; 157(7):2953-60. PubMed ID: 8816402
    [Abstract] [Full Text] [Related]

  • 17. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.
    Neipp M, Zorina T, Domenick MA, Exner BG, Ildstad ST.
    Blood; 1998 Nov 01; 92(9):3177-88. PubMed ID: 9787154
    [Abstract] [Full Text] [Related]

  • 18. 17α-Ethinyl-androst-5-ene-3β, 17β-diol, a Novel Potent Oral Radioprotective Agent, Confers Radioprotection of Hematopoietic Stem and Progenitor Cells in a Granulocyte Colony-Stimulating Factor-Independent Manner.
    Bai F, Wang L, Li Z, Yi L, Zuo Z, Zhang C, Shan Y, Yang C, Peng R, Yang R, Yu Z, Cong Y.
    Int J Radiat Oncol Biol Phys; 2019 Jan 01; 103(1):217-228. PubMed ID: 30103023
    [Abstract] [Full Text] [Related]

  • 19. Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.
    Huang Y, Ratajczak MZ, Reca R, Xu H, Tanner M, Rezzoug F, Hussain LR, Fugier-Vivier I, Bolli R, Ildstad ST.
    Transplantation; 2008 Apr 27; 85(8):1175-84. PubMed ID: 18431239
    [Abstract] [Full Text] [Related]

  • 20. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D, Gross A, Kosova N, Fichtner I, Salama A.
    Transfusion; 2005 Jul 27; 45(7):1192-200. PubMed ID: 15987366
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.